Chronic Obstructive Pulmonary Disease (COPD) Archives

ACP Offers Guidance on Antibiotic Duration for Common Infections

April 26, 2021

ACP recommends limiting antibiotic treatment duration to 5 days for COPD exacerbations and acute uncomplicated bronchitis.

COPD Information Center

Triple Therapy Improves COPD Outcomes, Regardless of Exacerbation History

By

Sheila Jacobs

March 10, 2021

Triple therapy with budesonide/glycopyrrolate/formoterol fumarate in patients with COPD, regardless of exacerbation history, reduced exacerbation rates compared with the use of glycopyrrolate/formoterol fumarate.

CHEST 2020 COPD In-depth

Acute COPD Exacerbations May Be Linked to Higher HbA1c Levels

By

Madeline Morr

November 4, 2020

Patients with chronic obstructive pulmonary disease (COPD) who have higher levels of HbA1c are at increased risk for hospital admission for acute exacerbations.

patient with tracheostomy and ventilator

CHEST 2020 COPD In-depth

Mechanically Ventilated Patients With COPD May Benefit From Early Tracheostomy

By

Britt Gambino

November 4, 2020

Researchers conducted a retrospective analysis of patients with COPD who were hospitalized and mechanically ventilated.

CHEST 2020 COPD In-depth

Switch to Extra-Fine Inhaled Triple Therapy Improves Regional Ventilation to Small Airways in COPD

By

Brandon May

November 4, 2020

Switching from non-extra fine multi-inhaler triple therapy to single-inhaler extra-fine inhaled triple therapy improved regional ventilation to the small airways in patients with COPD.

CHEST 2020 COPD In-depth

Cardiovascular Adverse Event Risk Following a COPD Exacerbation

By

Britt Gambino

November 4, 2020

In the first 30 days following an exacerbation of chronic obstructive pulmonary disease, there is an increased risk of cardiovascular adverse events.

COPD Information Center

Breztri Aerosphere Approved as Triple-Combination Therapy Inhaler for COPD

By

Brian Park, PharmD

August 4, 2020

The FDA has approved Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate; AstraZeneca) for the maintenance treatment of chronic obstructive pulmonary disease.

AANP 2019 Annual Meeting

Study Finds Tiotropium/Olodaterol Effective for Exacerbations of COPD

By

Madeline Morr

June 20, 2019

The DYNAGITO trial investigated the effectiveness of dual bronchodilation with fixed-dose tiotropium/olodaterol for reducing exacerbations of COPD.

20th Anniversary Clinical Pearl Giveaway

Collagen Degradation, Formation Elevated in Patients With Exacerbated COPD

By

Sheila Jacobs

July 25, 2018

Serologically assessed collagen remodeling plays a key role in the severity of COPD, as determined by airflow limitation and dyspnea, as well as in disease outcomes.